Serum Institute of India, which makes the most used Covid-19 vaccine in the country, on Saturday defended pricing Covishield vaccine at 1.5 times the initial rate, saying the earlier price was based on advance funding and now it has to invest in scaling up and expanding capacity to produce more shots.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3sNGjNk
No comments:
Post a Comment